Abstract
This paper is a detailed project proposal that is aimed at addressing the problem of the chronic kidney disease and to reduce the cases of the end stage renal disease occurrence .The major goal of the project is to reduce the new cases the chronic kidney disease together with its related complications, economic costs, death and the disability.
Introduction
Chronic kidney disease (CKD) is sequential loss in the functioning of the renal over a period of years or even months. It is also referred to as chronic renal disease (Peralta, 2009, p 364). It leads to deterioration of the kidney function as the kidney becomes incapable of excreting the waste products from the body. The kidney remove the wastes and the excess fluid from the body and flush them as urine (Peralta, 2009, p.364).
Chronic kidney disease is usually classified in five stages. The stage first (stage 1) is usually mild and cause few complications the final stage, stage 5 is the most harmful stage of the CKD. It is commonly referred to as end stage renal disease.
According to Coppo (2010), the end stage of the chronic kidney disease is characterized by symptoms such as loss of appetite, nausea, headaches, urinating less than normal et cetra.
The major causes of this disease are hypertension, diabetes mellitus and possibly glomerulonephritis (Coppo, 2010,p.993)
Objectives
The main goal of this research is to reduce the number of new cases of end stage renal disease (ESRD) and its related economic costs, death, disability and other complications.
This goal is very important in reduction in the kidney disease burden, elimination of the disparities among the kidney patients and more importantly improvement of the quality of life for people with chronic kidney disease.
The Project
Heath promotion is the most desired goal of the dialysis treatment. When the highest level of functioning is achieved it improves the life of the patient as well as rewards the staff through the positive response the improvement comes with (Coppo, 2010,p.993)
Health promotion can be achieved through the application of four Es’model. The four Es stand for the following:
Encouragement; this means giving the patients hope thus enabling them develop a positive attitude and high expectations of living longer than they may have conceived in mind. This can be well achieved through provision of free guidance and counseling to the CKD patients at the health centre (Coppo, 2010,p.993)
Evaluation of the patients should be individualized and periodic. It is good to assign a particular patient to a specific doctor. This is important because it a specific doctor keep track of the progress of the patient through regular assessment (Lewis, 2011,p.639)
Education is also important in the health promotion program. It is in order to enlighten the patients about this disease. Education prepares them for responsibility taking and participation in the fight against the disease (Lewis, 2011,p.639)
It is also important for the healthy people to be educated on how to lead a healthy life free from chronic kidney disease by giving them facts about the disease, that is, the causes and symptoms
Exercise improves the health standards and maintains overall physical fitness of people thus leading to the wellbeing of an individual. It is pertinent to note that, research has shown that consistent exercise at any level of CKD can help fight the progression of the chronic kidney disease (Lewis, 2011, p.640)
Conclusion
In many countries, ESRD is the major source of poor quality of life and suffering for those afflicted. It the cause of most premature deaths and high economic cost not mention disability (Peralta, 2009, p.364).
However, we have seen that this can be contained through proper health promotion program. Contacting chronic kidney disease can be avoided and it is curable through this health promotion program.
References
Coppo, R.(2010). Predictors of the out come in Henoch-Schonlein nephritis in children and adults. NewYork: Williams and sons publishers.
Devoto, M., & Romeo, G. (2008). Toc. Advances in Chronic Kidney Disease, 15(1), A7-A8.
Lewis,E,J.(2011).Effects of losartan on renal and cardiovascular outcomes in patients, Prentice Hall: Pearson Education Limited.
Peralta, C,A.(2009).the metabolic syndrome and chronic kidney disease. Curr Opin: Nephrol Hypertens.
Singh, A. K (2003). Masthead. American journal of kidney diseases, 41(6), A3.
